Jiangsu Bioperfectus Technologies Co Ltd (688399) — Capital Reinvestment Ratio

Latest as of September 2025: 1.00x

Jiangsu Bioperfectus Technologies Co Ltd (688399) has a Capital Reinvestment Ratio of 1.00x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥20.00 Million) in capital expenditures (CN¥20.05 Million). Check Jiangsu Bioperfectus Technologies Co Ltd (688399) tangible net worth to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

1.00x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥20.00 Million
CNY

Capital Expenditures

CN¥20.05 Million
CNY

Data as of

Sep 2025
Most recent filing

Jiangsu Bioperfectus Technologies Co Ltd Capital Reinvestment Ratio (2016–2024)

This chart tracks Jiangsu Bioperfectus Technologies Co Ltd's Capital Reinvestment Ratio across 8 annual periods. For the full cash flow conversion analysis, see Jiangsu Bioperfectus Technologies Co Ltd cash flow conversion.

Annual Capital Reinvestment Ratio for Jiangsu Bioperfectus Technologies Co Ltd (2016–2024)

Year-by-year Capital Reinvestment Ratio for Jiangsu Bioperfectus Technologies Co Ltd from 2016 to 2024. See 688399 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2024 0.43x CN¥145.93 Million CN¥62.86 Million ▲ +141.3%
2022 0.18x CN¥1.96 Billion CN¥350.74 Million ▼ -42.1%
2021 0.31x CN¥985.52 Million CN¥303.62 Million ▲ +114.3%
2020 0.14x CN¥935.88 Million CN¥134.56 Million ▼ -85.5%
2019 0.99x CN¥106.72 Million CN¥105.77 Million ▼ -13.9%
2018 1.15x CN¥85.82 Million CN¥98.74 Million ▲ +141.8%
2017 0.48x CN¥61.59 Million CN¥29.31 Million ▼ -53.0%
2016 1.01x CN¥22.09 Million CN¥22.37 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow